
Episode #79
Aprea Therapeutics - $APRE - Ep:079 - Nano Cap Podcast
In this episode, Oren Gilad, CEO of Aprea Therapeutics, shares insights into targeted cancer therapies, the science behind synthetic lethality, and the company's latest clinical progress. Discover how innovative approaches are changing the paradigm of cancer treatment and what the future holds. Aprea Therapeutics: https://aprea.com/ Nano Cap Podcast: https://www.nanocappod.com/ DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.






